Inhibition of human MCF-7 breast cancer growth by free radicals enhancement of polycondensed thienopyrimidine derivatives

Asian Journal of Pharmaceutical and Clinical Research

Volumn 4, Issue SUPPL. 1, 2011, Pages 118-122

  Mahmoud, Abeer E ^a   Ali, Mamdouh M ^a   Rashad, Aymn E ^a  

^a NATIONAL RESEARCH CENTRE   (Egypt)

Author keywords

Anticancer; Antioxidant; MCF 7 cell line; Thienopyrimidine

Indexed keywords

3 (4,5 DIMETHYL 2 THIAZOLYL) 2,5 DIPHENYLTETRAZOLIUM BROMIDE; ANTINEOPLASTIC AGENT; CATALASE; FREE RADICAL; GLUTATHIONE; GLUTATHIONE PEROXIDASE; GLUTATHIONE REDUCTASE; HYDROGEN PEROXIDE; INDENO[1',2':4,5]THIENO[2,3 D][1,2,3]TRIAZINE DERIVATIVE; INDENO[1',2':4,5]THIENO[2,3 D][1,2,4]TRIAZOLO[4,3 A]PYRIMIDINE DERIVATIVE; INDENO[1',2':4,5]THIENO[2,3 D][1,3]THIAZOLO[3,2 A]PYRIMIDINE DERIVATIVE; INDENO[1',2':4,5]THIENO[2,3 D]PYRIMIDINE DERIVATIVE; INDENO[2,1 B]THIOPHENE DERIVATIVE; NITRIC OXIDE; SUPEROXIDE DISMUTASE; THIENO[3,2 D]PYRIMIDINE DERIVATIVE; UNCLASSIFIED DRUG;

ANTINEOPLASTIC ACTIVITY; ARTICLE; BREAST CANCER; CANCER GROWTH; CANCER INHIBITION; CELL STRAIN MCF 7; COLORIMETRY; CONCENTRATION RESPONSE; CONTROLLED STUDY; DNA CONTENT; DRUG EFFECT; DRUG POTENCY; ENZYME ACTIVITY; ENZYME INHIBITION; HUMAN; HUMAN CELL; IC 50; LIPID PEROXIDATION; MALE; NONHUMAN; RAT; RNA ANALYSIS; UPREGULATION;

EID: 80052893498     PISSN: 09742441     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (33)

1. Tsuchiya T, Takagi Y, Yamada H. Preparation of 5-(2,6-Dideoxy-2-fluoro-α-L-talopyranosyloxy)-6-hydroxynaphtho [2,3-flquinoline-7,12-dione (FT-Alz), a new-type, potentially antitumor substance with various biological activities. Bioorg Med Chem Lett. 2000; 10: 203-207.
2. Suffness M, Pezzuto JM. Methods in Plant Biochemistry. Academic press. 1991; New York, pp. 71-96.
3. Rashad AE, Heikal OA, El-Nezhawy AOH, Abdel-Megeid FME. Synthesis and isomerization of thienotriazolopyrimidine and thienotetrazolo pyrimidine derivatives with potential anti-inflammatory activity. Heteroatom Chem. 2005; 16: 226-234.
4. De Clercq E. Chemotherapeutic approaches to the treatment of the acquired immune deficiency syndrome (AIDS). J Med Chem. 1986; 29: 1561-1569.
5. Amr AE, Hegab MI, Ibrahim AA, Abdalah MM. Synthesis and reactions of some fused oxazinone, pyrimidinone, thiopyrimidnone and triazinone derivatives with thiophene ring as analgesic, anticonvulsant and antiparkinsonian agents. Monatsh Chem. 2003; 134: 1395-1409.
6. Hassan NA, Hegab MI, Rashad AE, Fahmy AA, Abdel-Megeid FME. Synthesis and antimicrobial activity of some cyclic and acyclic nucleosides of thieno[2,3-d]pyrimidines. Nucleosides, Nucleotides and Nucleic Acids 2007; 26: 379-390.
7. Rashad AE, Ali MA. Synthesis and antiviral screening of some thieno[2,3-d]pyrimidine nucleosides Nucleosides, Nucleotides and Nucleic Acids 2006; 25: 17-28.
8. Das AK. A text book on medicinal aspects of bio-inorganic chemistry. India: CBS; 1990.
9. Cross CE, Halliwell B, Borish ET. Oxygen radicals and human disease. Annals Intern Med.1987; 107: 526-545.
10. Rashad AE, Shamroukh AH, Randa EAM, El-Sayed WA. Synthesis, reactions, and antimicrobial evaluation of some polycondensed thienopyrimidine derivatives. Synthetic Communications 2010; 40: 1149-1160.
11. Vistica DT, Skehan P, Scudiero D, Monks A, Pittman A, Boyd MR. Tetrazolium-based assays for cellular viability-a critical examination of selected parameters affecting formazan production.Cancer Res. 1991; 51: 2515-2520.
12. Paglia ED, Valentine WN. Studies on the quantitative and qualitative characterization of erythrocytes glutathione peroxidase. J Lab Clin Med. 1967; 70: 158-169.
13. Aebi H. Method of enzymatic analysis. New York: Academic press; 1984.
14. Marklund S, Marklund G. Involvement of superoxide anion radical in the autooxidation of pyrogallol and a convenient assay for superoxide dismutase. Eur J Biochem. 1974; 47: 469-474.
15. Carlberg I, Mannervik B. Glutathione reductase. Meth Enzymol. 1985; 113: 484-490.
16. Wolff SP. Ferrus ion oxidation in presence of ferric ion indicator xylenol orange for measurement of hydroperoxides. Meth Enzymol. 1994; 233: 182-189.
17. Granger DL, Taintor RR, Boockvar KS, Hibb JB, Jr. Determination of nitrate and nitrite in biological samples using bacterial nitrate reductase coupled with the Griess reaction. Methods 1995; 7: 78-83.
18. - / - mice to study metallothionein and oxidative stress. Free Rad Biol Med. 2000; 28(3): 447-462.
19. Ellman GL. Tissue sulfhydryl groups. Arch Biochem Biophys. 1959; 82, 70-77.
20. Zhou T, Zhou G, Song W, Eguchi N, Lu W, Lundin E, et al. Cadmium-induced apoptosis and changes in expression of p 53, c-jun, and MT-1 genes in testes and ventral prostste of rats. Toxicol. 1999; 142: 1-13.
21. Lowry OH, Rosebrough NJ, Farr AL, Randall RJ. Protein measurement with the folin phenol reagent. J Biol Chem. 1951; 193: 265-275.
22. Mazel P. Fundamental of drug metabolism and drug disposition. In: La-Du BN, Mandel HG, Way EL, editors. London: Baltimore; 1971. p. 546-600.
23. Melo PS, Durian N, Haun M. Cytotoxicity of derivatives from dehydrocrotonin on V79 cells and Echerichia Coli. Toxicol. 2001; 159: 135-141.
24. Blanco FJ, Ochs RL, Schwarz H, Lotz M. Chondrocyte apoptosis induced by nitric oxide. Am J Pathol. 1995; 146: 75-85.
25. MolinayVedia L, McDonald B, Reep B, Brne B, Di Silvio M, Billiar TR, et al. Nitric oxide-induced S-nitrosylation of glyceraldehyde- 3 phosphate dehydrogenase inhibits enzymatic activity and increases endogenous ADP-ribosylation. J Biol Chem. 1992; 267: 24929-24932.
26. Juedes MJ, Wogan GN. Peroxynitrite-induced mutation spectra of pSP189 following replication in bacteria and in human cells. Mutat Res.1996; 349: 51-61.
27. Hibbs JJ, Taintor RR, Vavrin Z, Rachlin EM. Nitric oxide: A cytotoxic activated macrophage effector molecule. Biophys Res Commun. 1988; 157: 87-94.
28. Lepoivre M, Fieschi F, Coves J, Thelander L, Fontecave M. nactivation of ribonucleotide reductase by nitric oxide. iochem Biophys Res Commun. 1991; 179: 442-448.
29. Fehsel K, Jalowy A, Qi S, Burkart V, Hartmann B, Kolb H. sletcell DNA is a target of inflammatory attack by nitric oxide. Dabetes 1993; 42: 496-500.
30. Dimmeler S, Zeiher AM. Nitric oxide and apoptosis: Another paradigm for the double-edged role of nitric oxide. itric Oxide 1997; 1: 275-281.
31. Bienvenu P, Caron L, Gasparutto D, Kergonou JF. ssessing and counteracting the pro-oxidant effects of anticancer drugs. XS. 1992; 62: 257-265.
32. Huang P, Feng L, Oldham EA, Keating MJ, Plunkett W. Superoxide dismutase as a target for the selective killing of cancer cells. Nature 2000; 407: 390-395.
33. Gewirtz DA. A critical evaluation of the mechanisms of action proposed for the antitumor effects of the anthracycline antibiotics adriamycin and daunorubicin. Biochem Pharmacol. 1999; 57: 727-741.